查看购物车
  • Traditional Chinese
  • English
2021-2031年北美栓塞器材市场报告：范围、细分、动态与竞争分析
市场调查报告书
商品编码
1871489

2021-2031年北美栓塞器材市场报告：范围、细分、动态与竞争分析

North America Embolization Devices Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 181 Pages | 订单完成后即时交付

价格

预计北美栓塞器械市场将大幅成长，到 2031 年将达到约 24.0442 亿美元，高于 2024 年的 12.426 亿美元，2025 年至 2031 年的年复合成长率(CAGR) 预计为 10.0%。

执行摘要和市场分析

北美栓塞器械市场的成长得益于该地区先进的医疗保健体系、血管疾病发病率的上升以及人们对微创手术日益增长的偏好。技术创新大大提高了栓塞技术的精准性和安全性，使其成为治疗动脉瘤、动静脉畸形和肿瘤等疾病的首选方法。患者对疾病和治疗方案的高度认知、完善的医疗报销体係以及领先医疗器材製造商的存在，共同推动了北美栓塞器材市场的成熟。公共卫生措施在推广栓塞手术方面也发挥着至关重要的作用。持续的研究和临床试验正在拓展栓塞技术的应用范围，特别关注可生物降解和药物洗脱栓塞剂。儘管美国在栓塞器械的应用和创新方面处于领先地位，但加拿大和墨西哥正透过扶持政策和基础设施的改善，逐步提升其市场份额。然而，城乡医疗资源分配不均仍是一项挑战。该地区持续吸引医院、研究机构和设备製造商之间的大量投资和合作，从而确保栓塞技术的持续发展和创新。

市场区隔分析

北美栓塞器械市场可按类型、应用和最终用户进行细分。

  • 依类型划分：市场产品包括栓塞线圈、栓塞塞、栓塞珠、栓塞胶等。 2024年，栓塞线圈占据最大的市场份额，并进一步细分为中心栓塞和周边栓塞。
  • 按应用领域划分：市场分为神经病学、週边血管疾病、肿瘤学、泌尿学和其他领域，其中神经病学在 2024 年将成为领先领域。
  • 按最终用户划分：市场分为医院、门诊中心和其他，到 2024 年，医院将占据市场份额的主导地位。

市场展望

诸如改进的导管设计、新型栓塞剂和可脱卸弹簧圈等创新技术提高了栓塞手术的疗效和安全性。例如，血流导向装置透过将血流从动脉瘤囊引流，促进动脉瘤内血栓形成，彻底改变了复杂颅内动脉瘤的治疗方法。临床研究对于推进栓塞技术至关重要，有助于扩大适应症范围并改善患者预后。由Fluidx Medical Technology公司开发的IMPASS栓塞弹簧圈装置透过栓塞脑膜中动脉，在治疗慢性硬脑膜下血肿方面展现出良好的前景，体内研究也证实了其有效性。美国FDA于2024年5月批准了Fluidx公司的GPX栓塞装置的研究性器械豁免（IDE）申请，相关积极结果发表在《血管与介入放射学杂誌》上，表明该装置具有很高的技术成功率和良好的临床评价。

在首次人体试验中评估的卡特彼勒动脉栓塞系统，证实其能有效闭塞週边动脉，且严重不良事件风险极低。随着市场的发展，临床研究与器材创新之间的合作对于满足日益增长的有效栓塞疗法需求至关重要。将临床研究融入栓塞器械的研发正成为重要趋势，可望拓展治疗选择并改善病患预后。

国家概况

北美栓塞器械市场涵盖美国、加拿大和墨西哥，其中美国在2024年占据最大的市场份额。美国市场的特点是创新水平高、新技术应用迅速，并且高度重视微创治疗。微创手术（MIS）的趋势日益增长，医疗机构倾向于采用栓塞术治疗肝细胞癌（HCC）、子宫肌瘤和脑动脉瘤等疾病，因为与传统手术相比，栓塞术风险更低、恢復更快。美国市场受益于对医疗技术的巨额投资以及强有力的临床研究，这些都支持栓塞疗法的有效性。

公司简介

栓塞器械市场的主要参与者包括美敦力、库克医疗、史赛克、波士顿科学、泰尔茂、强生、雅培等。这些公司正透过扩张、产品创新、併购等策略来提升市场占有率并提供创新产品。

目录

第一章：引言

第二章：执行概要

  • 关键见解

第三章：研究方法

  • 二手研究
  • 初步研究
    • 假设的提出：
    • 宏观经济因素分析：
    • 发展基数：
    • 数据三角测量：
    • 国家层面资料：
  • 假设和局限性

第四章：北美栓塞器材市场概况

  • 概述
  • PEST分析
  • 定价分析
    • 主要品牌定价分析

第五章：北美栓塞器材市场－主要市场动态

  • 北美栓塞器材市场－主要市场动态
  • 市场驱动因素
    • 临床疾病盛行率上升
    • 对微创技术的需求日益增长
  • 市场限制
    • 栓塞术期间或之后出现的併发症
  • 市场机会
    • 新产品开发及市场推广审批
  • 未来趋势
    • 透过临床创新变革栓塞治疗
  • 驾驶员和安全带的影响：

第六章：栓塞器械市场－北美分析

  • 2021-2031年北美栓塞器材市场收入
  • 北美栓塞器材市场预测分析

第七章：北美栓塞器材市场分析－依产品类型划分

  • 栓塞线圈
  • 插头
  • 珠
  • 胶水
  • 其他的

第八章：北美栓塞器材市场分析－依应用领域划分

  • 神经病学
  • 週边血管疾病
  • 肿瘤学
  • 泌尿科
  • 其他的

第九章：北美栓塞器材市场分析－依最终使用者划分

  • 医院
  • 门诊中心
  • 其他的

第十章：北美栓塞器材市场－国别分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

第十一章：竞争格局

  • 关键参与者热力图分析
  • 公司定位与集中度

第十二章：行业概况

  • 概述
  • 扩张
  • 新产品开发与审批
  • 併购
  • 伙伴关係与合作

第十三章：公司简介

  • Medtronic Plc
  • Cook Medical Holdings LLC
  • Stryker Corp
  • Boston Scientific Corp
  • Terumo Corp
  • Johnson & Johnson
  • Abbott Laboratories
  • NeuroSafe Medical Co. Ltd
  • Wallaby Medical
  • Sirtex Medical Ltd
  • GEM srl
  • Penumbra Inc.
  • Balt
  • Lepu Medical Technology Beijing Co Ltd
  • INVAMED
  • Meril Life Sciences Pvt Ltd
  • Merit Medical Systems Inc
  • Lifetech Scientific Corp

第十四章：附录

Product Code: BMIRE00032146

The North America embolization devices market is projected to grow significantly, reaching approximately US$ 2,404.42 million by 2031, up from US$ 1,242.60 million in 2024, with an estimated compound annual growth rate (CAGR) of 10.0% from 2025 to 2031.

Executive Summary and Market Analysis

The growth of the embolization devices market in North America is fueled by the region's advanced healthcare systems, rising incidence of vascular diseases, and an increasing preference for minimally invasive procedures. Technological innovations have greatly improved the precision and safety of embolization techniques, making them the preferred treatment for conditions like aneurysms, arteriovenous malformations, and tumors. High levels of patient awareness regarding medical conditions and treatment options, robust healthcare reimbursement frameworks, and the presence of leading medical device manufacturers contribute to the market's maturity in North America. Public health initiatives also play a vital role in promoting embolization procedures. Ongoing research and clinical trials are expanding the applications of embolization technologies, particularly focusing on biodegradable and drug-eluting embolic agents. While the United States leads in adoption and innovation, Canada and Mexico are gradually enhancing their market presence through supportive policies and infrastructure improvements. However, disparities in healthcare access between urban and rural areas pose challenges. The region continues to attract significant investments and collaborations among hospitals, research institutions, and device manufacturers, ensuring ongoing development and innovation in embolization technologies.

Market Segmentation Analysis

The North America embolization devices market can be segmented by type, application, and end user.

  • By Type: The market includes embolization coils, plugs, beads, glues, and others. In 2024, embolization coils held the largest market share, further divided into central and peripheral applications.
  • By Application: The market is categorized into neurology, peripheral vascular disease, oncology, urology, and others, with neurology being the leading segment in 2024.
  • By End User: The market is segmented into hospitals, ambulatory centers, and others, with hospitals dominating the market share in 2024.

Market Outlook

Innovations such as enhanced catheter designs, new embolic agents, and detachable coils have improved the efficacy and safety of embolization procedures. For instance, flow-diverting devices have transformed the treatment of complex intracranial aneurysms by redirecting blood flow away from the aneurysm sac, promoting thrombosis within the aneurysm. Clinical studies are crucial for advancing embolization techniques, leading to broader indications and better patient outcomes. The IMPASS embolic coil device, developed by Fluidx Medical Technology, has shown promise in treating chronic subdural hematomas by embolizing the middle meningeal artery, with in-vivo studies demonstrating its effectiveness. The US FDA granted Investigational Device Exemption (IDE) approval for Fluidx's GPX embolic device in May 2024, with positive results published in the Journal of Vascular and Interventional Radiology, indicating high technical success and favorable physician feedback.

The Caterpillar Arterial Embolization System, assessed in a first-in-human study, demonstrated effective occlusion in peripheral arteries with minimal risk of serious adverse events. As the market evolves, the collaboration between clinical research and device innovation will be essential in meeting the increasing demand for effective embolization therapies. Integrating clinical studies into the development of embolization devices is emerging as a significant trend, leading to expanded treatment options and improved patient outcomes.

Country Insights

The North America embolization devices market includes the US, Canada, and Mexico, with the US holding the largest market share in 2024. The US market is characterized by high innovation levels, early adoption of new technologies, and a strong focus on minimally invasive treatments. The trend towards minimally invasive surgeries (MIS) has been increasing, with healthcare providers favoring embolization procedures for conditions like hepatocellular carcinoma (HCC), uterine fibroids, and brain aneurysms due to their lower risk and quicker recovery times compared to traditional surgeries. The US market benefits from substantial investments in medical technology and robust clinical research supporting the efficacy of embolization therapies.

Company Profiles

Key players in the embolization devices market include Medtronic, Cook Medical, Stryker, Boston Scientific, Terumo, Johnson & Johnson, Abbott Laboratories, and others. These companies are pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. North America Embolization Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Pricing Analysis
    • 4.3.1 Pricing Analysis by Key Brands

5. North America Embolization Devices Market - Key Market Dynamics

  • 5.1 North America Embolization Devices Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Prevalence of Clinical Conditions
    • 5.2.2 Burgeoning Demand for Minimally Invasive Techniques
  • 5.3 Market Restraints
    • 5.3.1 Complications Arising During or After Embolization
  • 5.4 Market Opportunities
    • 5.4.1 New Product Developments and Marketing Approvals
  • 5.5 Future Trends
    • 5.5.1 Transforming Embolization Through Clinical Innovation
  • 5.6 Impact of Drivers and Restraints:

6. Embolization Devices Market - North America Analysis

  • 6.1 North America Embolization Devices Market Revenue (US$ Million), 2021-2031
  • 6.2 North America Embolization Devices Market Forecast Analysis

7. North America Embolization Devices Market Analysis - by Product Type

  • 7.1 Embolization Coils
    • 7.1.1 Overview
    • 7.1.2 Embolization Coils: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Plugs
    • 7.2.1 Overview
    • 7.2.2 Plugs: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Beads
    • 7.3.1 Overview
    • 7.3.2 Beads: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Glues
    • 7.4.1 Overview
    • 7.4.2 Glues: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Embolization Devices Market Analysis - by Application

  • 8.1 Neurology
    • 8.1.1 Overview
    • 8.1.2 Neurology: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Peripheral Vascular Disease
    • 8.2.1 Overview
    • 8.2.2 Peripheral Vascular Disease: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Oncology
    • 8.3.1 Overview
    • 8.3.2 Oncology: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Urology
    • 8.4.1 Overview
    • 8.4.2 Urology: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Embolization Devices Market Analysis - by End User

  • 9.1 Hospitals
    • 9.1.1 Overview
    • 9.1.2 Hospitals: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Ambulatory Centers
    • 9.2.1 Overview
    • 9.2.2 Ambulatory Centers: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Embolization Devices Market - Country Analysis

  • 10.1 North America
    • 10.1.1 North America Embolization Devices Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 North America Embolization Devices Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 United States: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 United States: North America Embolization Devices Market Share - by Product Type
        • 10.1.1.2.2 United States: North America Embolization Devices Market Share - by Embolization Coils
        • 10.1.1.2.3 United States: North America Embolization Devices Market Share - by Application
        • 10.1.1.2.4 United States: North America Embolization Devices Market Share - by End User
      • 10.1.1.3 Canada: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 Canada: North America Embolization Devices Market Share - by Product Type
        • 10.1.1.3.2 Canada: North America Embolization Devices Market Share - by Embolization Coils
        • 10.1.1.3.3 Canada: North America Embolization Devices Market Share - by Application
        • 10.1.1.3.4 Canada: North America Embolization Devices Market Share - by End User
      • 10.1.1.4 Mexico: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 Mexico: North America Embolization Devices Market Share - by Product Type
        • 10.1.1.4.2 Mexico: North America Embolization Devices Market Share - by Embolization Coils
        • 10.1.1.4.3 Mexico: North America Embolization Devices Market Share - by Application
        • 10.1.1.4.4 Mexico: North America Embolization Devices Market Share - by End User

11. Competitive Landscape

  • 11.1 Heat Map Analysis by Key Players
  • 11.2 Company Positioning and Concentration

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Expansion
  • 12.3 New Product Development and Approval
  • 12.4 Merger and Acquisition
  • 12.5 Partnerships and Collaboration

13. Company Profiles

  • 13.1 Medtronic Plc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Cook Medical Holdings LLC
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Stryker Corp
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Boston Scientific Corp
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Terumo Corp
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Johnson & Johnson
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Abbott Laboratories
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 NeuroSafe Medical Co. Ltd
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Wallaby Medical
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Sirtex Medical Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 GEM srl
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Penumbra Inc.
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Balt
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Lepu Medical Technology Beijing Co Ltd
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 INVAMED
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 Meril Life Sciences Pvt Ltd
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 Merit Medical Systems Inc
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 Lifetech Scientific Corp
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Embolization Devices Market Segmentation
  • Table 2. Pricing Analysis by Key Brands
  • Table 3. North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 4. North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Product Type
  • Table 5. North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 6. North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 7. North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 8. United States: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 9. United States: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 10. United States: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 11. United States: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 12. Canada: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 13. Canada: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 14. Canada: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 15. Canada: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 16. Mexico: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 17. Mexico: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 18. Mexico: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 19. Mexico: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 20. Glossary of Terms, Embolization Devices Market

List Of Figures

  • Figure 1. North America Embolization Devices Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Embolization Devices Market Revenue (US$ Million), 2021-2031
  • Figure 5. North America Embolization Devices Market Share (%) - by Product Type (2024 and 2031)
  • Figure 6. Embolization Coils: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Plugs: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Beads: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Glues: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Others: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. North America Embolization Devices Market Share (%) - by Application (2024 and 2031)
  • Figure 12. Neurology: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Peripheral Vascular Disease: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Oncology: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Urology: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Others: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. North America Embolization Devices Market Share (%) - by End User (2024 and 2031)
  • Figure 18. Hospitals: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Ambulatory Centers: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Others: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. North America Embolization Devices Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 22. United States: North America Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. Canada: North America Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Mexico: North America Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. Heat Map Analysis by Key Players
  • Figure 26. Company Positioning and Concentration